Primer on Tumor Immunology and Biological Therapy of Cancer

October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.

2010 Primer Webinar

Program Schedule
To view slides from a presenter click the icon next to the presentation title.

Friday, October 1

Session I: Basic Tumor Immunology
          8:05 am - 8:50 am Presentation SlidesInnate Immunity and Inflammation
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
          8:50 am - 9:35 am Presentation SlidesOverview of Adaptive Immunity
Emmanuel T. Akporiaye, PhD - Robert Franz Cancer Research Center,
                                               Earle A. Chiles Research Institute
          9:35 am - 10:20 am Presentation SlidesWill Dendritic Cells Help Us Address the Challenge of Cancer Vaccines?
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
          10:35 am - 11:20 am Presentation SlidesImmunotherapeutic Barriers at the Level of the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
          11:20 am - 12:05 pm Presentation SlidesRegulatory Immune Cells
James H. Finke, PhD - Cleveland Clinic Foundation

Session II: Clinical / Translational Cancer Immunology
          1:00 pm - 1:45 pm Presentation SlidesImmune Monitoring
Lisa H. Butterfield, PhD - University of Pittsburgh
          1:45 pm - 2:30 pm Presentation SlidesCytokines in Cancer Immunotherapy
Kim A. Margolin, MD - Seattle Cancer Center Alliance
          2:30 pm - 3:15 pm Immune Modulating Antibodies
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center
          3:30 pm - 4:15 pm Presentation SlidesCancer Vaccines
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute
          4:15 pm - 5:00 pm Adoptive T-Cell Therapy
Patrick Hwu, MD  - MD Anderson Cancer Center
    iSBTc 25th Annual Meeting
    For more information, click here

Saturday, October 2 - Monday, October 4

Creative Commons License
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.